B39.3

Clinical Causes: Inhalation of spores from contaminated environments, such as rich soil, bird or bat droppings Exposure during activities like gardening, construction, or spelunking in endemic areas Transmission primarily occurs through inhalation; human-to-human transmission is extremely rare Certain risk factors include HIV/AIDS, organ transplantation, cancer, and other conditions that suppress immune function

Key Symptoms: Fever and chills Fatigue and weakness Weight loss Shortness of breath Cough, which may be dry or productive Chest pain Enlargement of liver and spleen Skin rashes or lesions Mouth or throat ulcers Lymph node swelling In some cases, neurological symptoms such as headache or confusion if the central nervous system is involved

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests, which may include: - Blood tests detecting fungal antigens or antibodies - Cultures of blood, bone marrow, or tissue samples - Imaging studies like chest X-rays or CT scans to identify organ involvement - Biopsy of affected tissue for microscopic examination - Molecular methods such as PCR to detect fungal DNA It is crucial for healthcare providers to consider a patient's exposure history and immune status when evaluating symptoms.

Treatment Protocols: Treatment typically involves antifungal medications, which are administered for several weeks to months based on the severity and individual response. Common options include: - Amphotericin B for severe or disseminated cases - Itraconazole for long-term management and less severe cases - Supportive care to manage symptoms and prevent complications - Regular monitoring through clinical assessments and laboratory tests It is important to adhere to the prescribed treatment plan and follow-up with healthcare providers to ensure complete recovery.